1. Home
  2. FORA vs CPIX Comparison

FORA vs CPIX Comparison

Compare FORA & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forian Inc.

FORA

Forian Inc.

N/A

Current Price

$2.10

Market Cap

65.3M

Sector

Technology

ML Signal

N/A

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$3.77

Market Cap

59.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FORA
CPIX
Founded
2014
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
65.3M
59.5M
IPO Year
N/A
2009

Fundamental Metrics

Financial Performance
Metric
FORA
CPIX
Price
$2.10
$3.77
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
22.8K
218.7K
Earning Date
11-14-2025
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$28,106,911.00
$41,278,349.00
Revenue This Year
$51.82
N/A
Revenue Next Year
$7.24
N/A
P/E Ratio
N/A
N/A
Revenue Growth
37.47
12.21
52 Week Low
$1.64
$1.85
52 Week High
$4.03
$7.25

Technical Indicators

Market Signals
Indicator
FORA
CPIX
Relative Strength Index (RSI) 48.18 43.74
Support Level $2.08 $3.66
Resistance Level $2.13 $4.92
Average True Range (ATR) 0.03 0.40
MACD 0.00 -0.18
Stochastic Oscillator 66.85 9.09

Price Performance

Historical Comparison
FORA
CPIX

About FORA Forian Inc.

Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: